Synthesis and characterization of thiolated β-cyclodextrin as a novel mucoadhesive excipient for intra-oral drug delivery
Introduction
The intra-oral cavity is an ideal site for local drug delivery as it is open to direct visualization, which simplifies both agent placement and clinical monitoring (de Vries, Bodde, Verhoef, & Junginger, 1990). It is advantageous for the treatment of intra-oral conditions such as gingivitis, oral candidiasis, oral lesions, dental carries, xerostomia (dryness of mouth due to lack of saliva), oral cancer, mucositis and neuropathic pain. Furthermore, the mucosal linings of the oral cavity are robust, and regain rapidly after local stress or damage (Smart, 2004). The development of intra-oral drug delivery system, however, in most cases is challenging. In particularly, it is difficult to keep the drug for a prolonged period of time on the intra-oral mucosa. Swallowing of saliva can also potentially lead to the loss of dissolved or suspended drug and, ultimately, the involuntary removal of the dosage form (Salamat-Miller, Chittchang, & Johnston, 2005). To overcome these problems, mucoadhesive polymers (Andrews, Laverty, & Jones, 2009) in the form of mucoadhesive patches (Perioli et al., 2004), lozenges/tablets (Perioli et al., 2007) and mucoadhesive gums (Alur, Pather, Mitra, & Johnston, 1999) have been used, still, they bear the disadvantage of foreign sensation, leading to poor patient compliance and tongue tries to get rid of these dosage forms. Furthermore, inconvenience to the patients during eating and drinking, along with the threat of choking by involuntarily swallowing of the delivery system.
Therefore, the aim of this study was the development of a novel mucoadhesive intra-oral drug delivery system without having foreign sensation. Accordingly β-CD, the likely smallest drug carrier providing improved solubility of numerous poorly soluble drugs, was chosen. β-CD is a multifunctional excipient which is extensively being used in pharmaceutical industry (Gidwani & Vyas, 2014). β-CD was thiolated to acquire the desired mucoadhesive properties according to the synthetic pathway as outlined in Fig. 1. Thiolated polymers mimic the natural mechanism of secreted mucus glycoproteins, covalently anchored in the mucus layer by the formation of disulfide bonds, the bridging structure most commonly encountered in biological systems. Because of the protracted residence time of the mucoadhesive drug delivery systems at the site of drug action, the frequency of dosing can be reduced which can lead to an improved patient compliance.
Miconazole nitrate is a broad spectrum antifungal drug, which has poor water solubility with an octanol-water partition coefficient of about 6.25 emphasizing the lipophilic character of the nitrate salt (Bhalekar, Pokharkar, Madgulkar, Patil, & Patil, 2009). Poor water solubility and lack of absorption at the site of application makes it a challenging candidate for intra-oral use. Inclusion complexes with β-CD have been reported to increase the dissolution and solubility of miconazole nitrate paving the way for new oral and topical drug delivery systems (Pedersen et al., 1993). After thiolation of β-CD miconazole nitrate serving as model drug for intra-oral therapy was therefore, encapsulated and the potential of this novel delivery system was evaluated in vitro.
Section snippets
Materials
Beta-cyclodextrin (β-CD), Ellman's reagent (5,5-dithiobis (2-nitro-benzoic acid)), MES hydrate (4-morpholine-ethanesulfonic acid), TNBS (trinitrobenzensulfonic acid), cysteamine, cysteine HCl, ethylene glycol, t-butyl carbazate, rhodamine 123 (Rhod-123), sodium periodate (NaIO4), sodium cyanoborohydride (NaCNBH3), sodium borohydride (NaBH4), dimethyl sulfoxide (DMSO) and minimum essential medium eagle (MEM) were all purchased from Sigma-Aldrich, Vienna, Austria. Pre-treated standard grade
Characterization of β-CD-Cys conjugates
β-CD-Cys conjugates obtained via the covalent attachment of cysteamine to the oxidized β-CD were of white color and odorless having fibrous structure. Conjugation of primary amine such as cysteamine depends on the presence of carbonyl groups on β-CD, whereas, unmodified β-CD does not contain carbonyl groups necessary for the reaction with primary amines. Within this study increasing concentrations of NaIO4 were used to partially oxidize β-CD. The periodate oxidation reaction encompasses a
Conclusion
In this study cysteamine was successfully conjugated to the oxidized β-CD. It could be shown, that thiolation of β-CD can increase the potential of β-CD drug encapsulation property by imparting mucoadhesive properties. Synthesized β-CD-Cys conjugates (β-CD-Cys561, β-CD-Cys1054 and β-CD-Cys1783) displayed significantly increased intra-oral mucoadhesion along with enhanced solubilizing effects for lipophilic drugs. Mucoadhesive properties were verified by applying the β-CD-Cys conjugates onto the
Acknowledgments
All the expenses for this work were supported by the Higher Education Commission of Pakistan (HEC), the Austrian Agency for International Cooperation in Education and Research (ÖAD) and the FWF (Fonds zur Förderung der wissenschaftlichen Forschung) project No. ZFP 235150.
References (30)
- et al.
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride
Carbohydrate Polymers
(2012) - et al.
Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets
International Journal of Pharmaceutics
(1999) - et al.
Mucoadhesive polymeric platforms for controlled drug delivery
European Journal of Pharmaceutics and Biopharmaceutics
(2009) - et al.
Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder
International Journal of Pharmaceutics
(2011) Thiomers: A new generation of mucoadhesive polymers
Advanced Drug Delivery Reviews
(2005)- et al.
Synthesis, characterization and application of Epichlorohydrin-β-cyclodextrin polymer
Colloids and Surfaces B: Biointerfaces
(2014) - et al.
Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin
Journal of Pharmaceutical Sciences
(2009) - et al.
Development and in vivo evaluation of an oral drug delivery system for paclitaxel
Biomaterials
(2011) - et al.
Preactivated thiomers as mucoadhesive polymers for drug delivery
Biomaterials
(2012) - et al.
6-Triazolyl-6-deoxy-β-cyclodextrin derivatives: Synthesis, cellular toxicity, and phase-solubility study
Carbohydrate Research
(2014)